Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Kanabo Group PLC

Healthcare GB KNB

0.0022GBX
-0.2228(99.02%)

Last update at 2026-06-02T07:00:00Z

Day Range

0.00220.0022
LowHigh

52 Week Range

0.200.35
LowHigh

Fundamentals

  • Previous Close 0.23
  • Market Cap1.42M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.69900M
  • Revenue TTM1.14M
  • Revenue Per Share TTM0.002
  • Gross Profit TTM 0.09M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -7.99500M -6.87000M -4.55100M -0.13100M -0.36300M
Minority interest 0.00800M 0.00300M - - -
Net income -7.98700M -7.99700M -8.06800M -0.10600M -0.36100M
Selling general administrative 0.80M 1.36M 0.86M 0.12M 0.36M
Selling and marketing expenses 0.31M 0.44M 0.16M - -
Gross profit 0.13M 0.20M 0.00700M - -
Reconciled depreciation 1.45M 1.18M 0.00700M - -
Ebit -7.92300M -5.39200M -2.80400M -0.15600M -0.36500M
Ebitda -6.47100M -4.50600M -1.02700M -0.15600M -0.36500M
Depreciation and amortization 1.45M 0.89M 1.78M - -
Non operating income net other - - - - -
Operating income -7.79300M -5.39200M -2.80400M -0.15600M -0.36500M
Other operating expenses 8.69M 6.00M 2.88M 0.16M 0.36M
Interest expense 0.07M 0.06M 0.02M 0.00000M 0.00000M
Tax provision 0.00000M - 0.00000M 0.00000M 0.00000M
Interest income 0.02M 0.00000M 0.02M 0.03M 0.00200M
Net interest income -0.05400M -0.07100M 0.02M 0.03M 0.00200M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.20600M 1.13M 3.52M -0.02500M -0.00200M
Total revenue 0.90M 0.60M 0.07M 0.00000M -
Total operating expenses 7.93M 5.59M 2.81M 0.16M 0.36M
Cost of revenue 0.76M 0.40M 0.07M - -
Total other income expense net -0.20200M -1.47800M -1.74700M 0.03M 0.00200M
Discontinued operations - - - - -
Net income from continuing ops -7.99500M -6.87000M -4.55100M -0.13100M -0.36300M
Net income applicable to common shares - - -4.55100M -0.13100M -0.36300M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 8.35M 14.45M 5.60M 0.79M 0.71M
Intangible assets 4.73M 5.99M - - -
Earning assets - - - - -
Other current assets 0.08M - 0.27M 0.43M 0.01M
Total liab 0.85M 2.01M 0.41M 0.05M 0.04M
Total stockholder equity 7.51M 12.45M 5.18M 0.74M 0.67M
Deferred long term liab - - - - -
Other current liab 0.41M 1.15M 0.38M 0.04M 0.02M
Common stock 15.81M 10.57M 9.25M 0.73M 0.73M
Capital stock 15.81M 10.57M 9.25M 0.73M 0.73M
Retained earnings -20.72300M -13.60500M -6.74800M -0.78400M -0.71200M
Other liab - - - - -
Good will 0.00000M 4.05M - - -
Other assets - - - 0.01M 0.10M
Cash 1.68M 3.20M 4.48M 0.36M 0.60M
Cash and equivalents - - - - -
Total current liabilities 0.71M 1.50M 0.41M 0.05M 0.04M
Current deferred revenue - - - - -
Net debt -1.40900M -2.49700M -4.47700M -0.35900M -0.59700M
Short term debt 0.13M 0.20M - - -
Short long term debt 0.13M 0.13M 0.00000M - -
Short long term debt total 0.27M 0.71M - - -
Other stockholder equity 9.78M 15.48M 2.68M 0.79M 0.65M
Property plant equipment - - 0.04M 0.01M -
Total current assets 3.58M 4.00M 4.81M 0.79M 0.61M
Long term investments - - - - -
Net tangible assets - - 5.18M 0.74M 0.67M
Short term investments 1.53M 0.49M - - -
Net receivables 0.23M 0.04M 0.01000M 0.43M 0.01M
Long term debt 0.14M 0.28M - - -
Inventory 0.06M 0.08M 0.06M 0.03M -
Accounts payable 0.16M 0.15M 0.04M 0.01M 0.01M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 2.65M - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.03M 0.75M - 0.10M
Deferred long term asset charges - - - - -
Non current assets total 4.78M 10.45M 0.79M 0.00000M 0.10M
Capital lease obligations 0.00000M 0.30M - - -
Long term debt total - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -1.69500M 0.08M -1.01100M -0.30000M -0.09800M
Change to liabilities - - 0.12M 0.02M 0.02M
Total cashflows from investing activities -1.69500M - -1.01100M -0.30000M -0.10000M
Net borrowings -0.05100M - - 0.16M 0.16M
Total cash from financing activities 2.56M 2.40M 7.24M 0.16M -0.10000M
Change to operating activities - - 0.14M -0.02800M -
Net income -7.98700M -6.87000M -4.55100M -0.13100M -0.36300M
Change in cash -1.52300M -1.27300M 4.10M -0.23800M -0.44400M
Begin period cash flow 3.20M 4.48M 0.38M 0.60M 1.04M
End period cash flow 1.68M 3.20M 4.48M 0.36M 0.60M
Total cash from operating activities -2.52000M -3.77900M -2.07800M -0.10000M -0.34600M
Issuance of capital stock 2.74M 2.47M 7.24M - 0.00000M
Depreciation 1.45M 1.18M 0.00700M 0.00500M -
Other cashflows from investing activities -0.50800M - - -0.30000M -0.10000M
Dividends paid - - - - -
Change to inventory 0.03M -0.01800M -0.03500M 0.00900M -
Change to account receivables 0.02M - -0.20400M -0.02000M -0.02000M
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.08100M 0.03M 0.00200M -0.30000M 0.00200M
Change to netincome - - 2.44M 0.03M 0.03M
Capital expenditures 0.53M 0.15M 0.04M 0.04M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.58100M 0.87M 0.02M -0.00200M 0.02M
Stock based compensation 0.08M 0.97M 1.83M 0.03M -
Other non cash items 4.52M 0.07M 0.01M - -0.00200M
Free cash flow -3.05300M -3.93300M -2.11300M -0.10000M -0.34600M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
KNB
Kanabo Group PLC		 -0.2228 99.02% 0.0022 - - 1.25 0.24 0.07 -2.2141
CVSG
CVS Group Plc		 -1.0 0.08% 1233.00 50.87 12.08 1.18 2.69 1.52 9.51
SPI
Spire Healthcare Group Plc		 -0.5 0.23% 217.00 37.06 13.91 0.38 0.78 1.18 7.70
OHGR
One Health Group Plc		 - -% 251.50 24.09 18.15 1.06 2.75 0.75 10.53

Reports Covered

Stock Research & News

View All

Profile

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain. It also provides cultivation consultancy for cannabis businesses, as well as develops and distributes cannabis derived medicinal and wellness products. Kanabo Group Plc was incorporated in 2016 and is based in London, the United Kingdom.

Kanabo Group PLC

Churchill House, London, United Kingdom, NW4 4DJ

Key Executives

Name Title Year Born
Mr. Avihu Tamir CEO & Exec. Director 1981
Mr. David Sack Co-founder NA
Mr. Assaf Vardimon Chief Financial Officer 1978
Howard Rubenstein Company Sec. NA
Mr. Avihu Tamir CEO, Executive Director & Secretary 1981
Mr. Suleman Sacranie Chief Technology Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions